BBC News  |  April 14, 2023

“It is deeply concerning that appellate judges think they can micromanage FDA decisions for mifepristone and other FDA approved drugs,” said Lawrence Gostin, a lawyer and professor of global health law at Georgetown University. “These are scientific decisions that should not be made by lay judges.”

Read more here.